![]() |
市场调查报告书
商品编码
1859776
全球宠物生物安全解决方案市场:预测至 2032 年—按产品类型、应用、最终用户和地区分類的分析Pet Biosecurity Solutions Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User, and By Geography. |
||||||
根据 Stratistics MRC 的数据,全球宠物生物安全解决方案市场预计到 2025 年将达到 93 亿美元,到 2032 年将达到 268 亿美元,预测期内复合年增长率为 16.3%。
宠物生物安全解决方案是指旨在预防宠物间感染疾病传播的系统和措施。这些方案包括卫生通讯协定、疫苗接种计划、隔离程序以及有助于检测和控制健康风险的监测工具。其目标是保护动物免受病原体侵害,并确保家庭、诊所、收容所和公共场所的环境安全。解决方案包括物理屏障、卫生用品以及健康数据的数位追踪,以维护宠物健康并预防感染疾病爆发。
世界动物卫生组织表示,通用感染疾病的威胁日益加剧,加速了对先进诊断、疫苗和消毒通讯协定的需求,以确保犬舍和兽医诊所等设施的安全。
对通用感染疾病的认识提高
宠物生物安全解决方案市场的发展动力源于人们对通用感染疾病的日益关注,以及保护宠物和人类免受跨物种感染的迫切需求。在全球健康倡议和宠物卫生标准不断提高的推动下,饲主越来越重视预防保健和卫生用品。狂犬病和钩端螺旋体病等疾病爆发的报告日益增多,进一步刺激了市场需求。此外,兽医专业人员对早期发现和控制的重视也加速了相关产品的普及。因此,生物安全解决方案正成为宠物照护中不可或缺的一部分。
消费者意识低下
宠物饲主对生物安全措施的认知不足是限制市场扩张的主要因素。许多消费者除了定期接种疫苗外,对其他感染预防措施知之甚少。这种知识不足阻碍了消毒剂、清洁剂和抗菌寝具等预防性卫生产品的普及。此外,新兴地区教育宣传活动不足和产品供应短缺也加剧了这个问题。为了克服这项限制因素,兽医组织和生产者需要进行有针对性的宣传活动,以提高人们对宠物生物安全主动性重要性的认识。
开发创新卫生产品
先进创新卫生解决方案的开发为宠物生物安全解决方案市场带来了巨大的机会。在生物技术和材料科学进步的推动下,各公司纷纷推出长效消毒剂、病原体特异性喷雾剂和环保消毒剂。这些创新满足了宠物饲主对无毒和永续产品日益增长的偏好。此外,将智慧包装和自动化卫生系统整合到兽医环境中,进一步提升了安全性和便利性。这些技术进步有望重新定义宠物预防性卫生管理。
其他预防措施
疫苗、免疫增强补充剂和天然疗法等替代预防措施对市场成长构成显着威胁。许多宠物饲主更倾向于这些他们认为熟悉且价格低廉的解决方案。此外,频繁梳理毛髮和使用草药清洗等传统消毒方法也减少了对专业生物安全产品的依赖。这种替代效应可能会限制产品渗透率,尤其是在对价格敏感的市场。製造商必须强调其产品已证实的有效性和安全性优势,以应对其他预防方法的竞争。
新冠疫情显着提高了宠物饲主对卫生和病原体传播的认识,加速了生物安全解决方案的普及。初期,供应链和兽医服务的中断阻碍了产品的供应。然而,人们对宠物相关疾病传播媒介的日益关注,促使消毒剂、杀菌剂和防护设备的销售量激增。疫情后的復苏推动了动物收容所和诊所卫生通讯协定的製度化。因此,新冠疫情加速了全球宠物生物安全措施的长期制度化。
预计在预测期内,消毒剂和清洁剂细分市场将成为最大的细分市场。
由于消毒剂和清洁剂在消除宠物环境中的有害病原体方面发挥着至关重要的作用,预计在预测期内,该细分市场将占据最大的市场份额。这些产品广泛应用于诊所、收容所和家庭,以降低疾病传播的风险。人们对宠物卫生和安全饲养意识的提高进一步推动了市场需求。此外,无酒精和宠物安全配方的创新也巩固了其持续的受欢迎程度。凭藉其可靠性和广泛的应用范围,该细分市场正在巩固其市场主导地位。
预计在预测期内,兽医院细分市场将以最高的复合年增长率成长。
预计在预测期内,兽医院领域将实现最高成长率。兽医专业人员越来越依赖生物安全解决方案来保护动物和工作人员免受交叉感染。诊所正在采用先进的消毒剂、灭菌工具和隔离通讯协定,以符合监管指南。此外,宠物治疗量的增加以及人们对医院感染的认识不断提高,正在加速这些解决方案的采用,使兽医院成为一个高成长的终端用户领域。
由于宠物饲养量的增加、可支配收入的增长以及中国、日本和印度等国家兽医基础设施的不断完善,预计亚太地区将在预测期内占据最大的市场份额。人们对通用感染疾病的认识不断提高以及政府主导的动物健康计划也进一步推动了市场扩张。此外,全球生物安全公司不断增加的投资也增强了该地区的产品供应。这些因素共同促成了亚太地区成为宠物生物安全解决方案应用的重要中心。
在预测期内,北美预计将实现最高的复合年增长率,这主要得益于其先进的动物保健体系、较高的宠物消费支出以及对卫生创新技术的早期应用。美国和加拿大对高端生物安全产品的需求激增,这主要受严格的动物健康法规的推动。此外,主要市场参与者的强大实力和完善的分销网络也提高了产品的供应量。持续的产品创新和宣传宣传活动预计将继续推动该地区市场的快速成长。
According to Stratistics MRC, the Global Pet Biosecurity Solutions Market is accounted for $9.3 billion in 2025 and is expected to reach $26.8 billion by 2032 growing at a CAGR of 16.3% during the forecast period. Pet Biosecurity Solutions are systems and practices aimed at preventing the spread of infectious diseases among pets. These include hygiene protocols, vaccination programs, quarantine procedures, and monitoring tools that help detect and control health risks. The goal is to protect animals from pathogens and ensure safe environments in homes, clinics, shelters, and public spaces. Solutions may involve physical barriers, sanitation products, and digital tracking of health data to maintain wellness and prevent outbreaks.
According to the World Organisation for Animal Health, rising zoonotic disease threats are accelerating demand for advanced diagnostics, vaccines, and disinfection protocols to secure facilities like kennels and veterinary hospitals.
Rising zoonotic disease awareness
The Pet Biosecurity Solutions Market is being driven by increasing awareness of zoonotic diseases and the critical need to protect both pets and humans from cross-species infections. Fueled by global health initiatives and heightened pet hygiene standards, owners are prioritizing preventive care and sanitation products. Rising media coverage of outbreaks such as rabies and leptospirosis further reinforces demand. Additionally, veterinary professionals emphasize early detection and containment practices, accelerating product adoption. Consequently, biosecurity solutions are becoming indispensable in pet care.
Limited consumer awareness
Limited awareness among pet owners regarding biosecurity measures acts as a key restraint in market expansion. Many consumers remain unaware of infection control practices beyond routine vaccinations. This knowledge gap hinders adoption of preventive hygiene products like disinfectants, sanitizers, and antimicrobial bedding. Furthermore, insufficient education campaigns and product accessibility in emerging regions exacerbate the issue. Overcoming this restraint requires targeted outreach by veterinary organizations and manufacturers to promote the importance of proactive pet biosecurity.
Development of innovative hygiene products
The development of advanced and innovative hygiene solutions presents significant opportunities in the Pet Biosecurity Solutions Market. Spurred by advancements in biotechnology and materials science, companies are introducing long-lasting disinfectants, pathogen-specific sprays, and eco-friendly sanitizers. These innovations cater to the growing preference for non-toxic and sustainable products among pet owners. Additionally, integration of smart packaging and automated hygiene systems in veterinary settings enhances safety and convenience. This technological evolution is expected to redefine preventive pet health management.
Alternative preventive measures
Alternative preventive measures such as vaccines, immune-boosting supplements, and natural remedies pose a notable threat to market growth. Many pet owners prefer these solutions due to their familiarity and perceived lower cost. Moreover, traditional disinfection practices like frequent grooming or herbal cleaning reduce dependence on specialized biosecurity products. This substitution effect may limit product penetration, particularly in cost-sensitive markets. Manufacturers must emphasize proven efficacy and safety advantages to counter competition from alternative preventive approaches.
The COVID-19 pandemic significantly heightened awareness of hygiene and pathogen transmission among pet owners, accelerating adoption of biosecurity solutions. Initially, disruptions in supply chains and veterinary services hampered product availability. However, rising concerns over pet-related disease vectors boosted sales of sanitizers, disinfectants, and protective equipment. Post-pandemic recovery saw increased institutional adoption of hygiene protocols in shelters and clinics. Consequently, COVID-19 served as a catalyst for the long-term institutionalization of pet biosecurity practices worldwide.
The disinfectants & sanitizers segment is expected to be the largest during the forecast period
The disinfectants & sanitizers segment is expected to account for the largest market share during the forecast period, resulting from their critical role in eliminating harmful pathogens from pet environments. These products are extensively used in clinics, shelters, and households to reduce disease transmission risk. Growing awareness of pet hygiene and safe handling practices further enhances demand. Additionally, innovations in alcohol-free, pet-safe formulations support sustained adoption. This segment's reliability and broad applicability solidify its dominant market position.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate, propelled by rising implementation of strict sanitation standards and infection control measures. Veterinary professionals increasingly rely on biosecurity solutions to safeguard animals and staff from cross-contamination. Clinics are adopting advanced disinfectants, sterilization tools, and isolation protocols to comply with regulatory guidelines. Moreover, growing pet treatment volumes and awareness of hospital-acquired infections are accelerating adoption, making veterinary clinics a high-growth end-use segment.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to expanding pet ownership, rising disposable incomes, and growing veterinary infrastructure in countries like China, Japan, and India. Heightened awareness of zoonotic diseases and government-driven animal health programs further stimulate market expansion. Additionally, increasing investments by global biosecurity companies strengthen regional product availability. These factors collectively position Asia Pacific as a major hub for pet biosecurity solution adoption.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary healthcare systems, high pet expenditure, and early adoption of hygiene innovations. The U.S. and Canada are witnessing surging demand for premium biosecurity products supported by stringent animal health regulations. Furthermore, the strong presence of key market players and robust distribution networks enhances accessibility. Continuous product innovation and awareness campaigns are expected to sustain rapid market growth in the region.
Key players in the market
Some of the key players in Pet Biosecurity Solutions Market include 3M Company, Elanco Animal Health, BASF SE, Stockmeier Group, DuPont de Nemours, Inc., Kersia Group, Thermo Fisher Scientific Inc., Kemin Industries Inc., Ecolab Inc., Evonik Industries AG, Zoetis Inc., Solvay S.A., Neogen Corporation, BASF Animal Nutrition, Lanxess AG, Bayer Animal Health, GEA Group Aktiengesellschaft, and Merck Animal Health.
In September 2025, Zoetis presented new data on BRAVECTO(R) injectable at WSAVA Congress, highlighting rapid onset and safety. The company also donated its 7 millionth rabies vaccine through the Afya Program
In August 2025, Lanxess AG showcased Virkon(R), TH4+(R), and Hyperox(R) at IPPE 2025, reinforcing its leadership in animal biosecurity. The company emphasized sustainability and compliance in poultry and livestock hygiene
In April 2025, Stockmeier Group expanded its disinfectant portfolio in India via Saife Vetmed, launching enzymatic cleaners for livestock and companion animals. The collaboration targets Southeast Asia, Middle East, and Africa